| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/05/2009 | US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use |
| 03/05/2009 | US20090060874 Bicyclic pyrrolidine derivatives |
| 03/05/2009 | US20090060853 Aminophenylbenzothiazole compounds |
| 03/05/2009 | DE102007041115A1 Thiadiazinonderivate Thiadiazinonderivate |
| 03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
| 03/05/2009 | CA2697382A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/04/2009 | EP2030974A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 03/04/2009 | EP2030970A1 Allosteric modulators of metabotropic glutamate receptors |
| 03/04/2009 | EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 03/04/2009 | EP2029588A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 03/04/2009 | EP2029585A2 Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof |
| 03/04/2009 | EP2029584A2 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use |
| 03/04/2009 | EP2029583A1 New benzothiazinone derivatives and their use as antibacterial agents |
| 03/04/2009 | EP2029575A1 Substituted spirocyclic cgrp receptor antagonists |
| 03/04/2009 | EP2029572A2 Organic compounds |
| 03/04/2009 | EP2029562A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors |
| 03/04/2009 | EP2029560A2 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors |
| 03/04/2009 | EP2029559A1 Aryl-4-ethynyl-isoxazole derivatives |
| 03/04/2009 | EP2029547A1 Fxr agonists |
| 03/04/2009 | EP2029546A1 Aryl-substituted heterocycles, and use thereof |
| 03/04/2009 | EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/04/2009 | EP2029542A2 Primary amines as renin inhibitors |
| 03/04/2009 | EP2029532A2 Piperazine enamines as antiviral agents |
| 03/04/2009 | EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides |
| 03/04/2009 | EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 03/04/2009 | EP1781646A4 Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-i-piperazinyl)dibenzo[b,f][1,4]thiazepine |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | CN101379060A Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors |
| 03/04/2009 | CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 03/04/2009 | CN101379034A Benzamide and heteroarene derivatives as CETP inhibitors |
| 03/04/2009 | CN100465163C Cis-2,4,5-triaryl-imidazolines |
| 03/03/2009 | US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 03/03/2009 | US7498346 Chemokine receptor binding compounds |
| 03/03/2009 | US7498343 Mycobacterial inhibitors |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026346A1 Thiazolidine compounds, and methods of making and using same |
| 02/26/2009 | WO2009026345A1 Thiazolidinone compounds, and methods of making and using same |
| 02/26/2009 | WO2009026227A2 Highly selective sigma receptor ligands |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025358A1 Heterocyclic compound and use thereof |
| 02/26/2009 | WO2009025091A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/26/2009 | WO2009024905A1 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 02/26/2009 | WO2009024342A2 Novel microbiocides |
| 02/26/2009 | WO2009024341A2 Condensed anthran i lami de derivatives as insectisides |
| 02/26/2009 | WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | WO2009024221A1 6-thioxo-pyridazine derivatives |
| 02/26/2009 | WO2009024016A1 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl -propyl)-6,7-dihydro -1h- pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors |
| 02/26/2009 | WO2009003998A3 Antiproliferative compounds based on 5-membered heterocycles |
| 02/26/2009 | US20090054652 Cyanine Compound and Optical Recording Material |
| 02/26/2009 | US20090054643 Novel method of synthesis of fluoroquinolones |
| 02/26/2009 | US20090054642 Novel benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same |
| 02/26/2009 | US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 02/26/2009 | US20090054505 such as 5-(3-((R)-3-(4-((S)-1-hydroxyhexyl)phenyl)-4-oxooxazolidin-2-yl)propyl)thiophene-2-carboxylic acid, used for the reduction of intraocular pressure and treament of glaucoma |
| 02/26/2009 | US20090054494 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide |
| 02/26/2009 | US20090054493 Thiazole derivatives as ppar delta ligands and their manufacturing process |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054475 treatment of Type II diabetes and other diseases associated with poor glycemic control |
| 02/26/2009 | US20090054464 Hdac inhibitor |
| 02/26/2009 | US20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054436 anticarcinogenic compounds; ; N-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-2-bromoisonicotinamide, trifluoroacetic acid salt; inhibit the protein tyrosine kinase activity of growth factor receptors like Hepatocyte growth factor |
| 02/26/2009 | US20090054434 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054407 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054357 Macrolide compounds endowed with antiinflammatory activity |
| 02/26/2009 | US20090053172 Heterocyclic compounds as ccr5 antagonists |
| 02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | CA2696472A1 6-thioxopyridazine derivatives |
| 02/26/2009 | CA2695509A1 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 02/26/2009 | CA2694380A1 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl -propyl)-6,7-dihydro -1h- pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors |
| 02/26/2009 | CA2693067A1 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives |
| 02/25/2009 | EP2028185A1 Tubulysin and tubulysin agent |
| 02/25/2009 | EP2027143A2 Compounds and compositions as channel activating protease inhibitors |
| 02/25/2009 | EP2027121A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/25/2009 | EP2027107A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 02/25/2009 | EP2027091A1 New pharmaceutical compounds |
| 02/25/2009 | EP1904476B1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 02/25/2009 | EP1521752B1 Macrocycles for the treatment of cancer |
| 02/25/2009 | EP1381361B1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/25/2009 | CN101374836A Muscarinic agonists and methods of use thereof |
| 02/25/2009 | CN101374835A Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
| 02/25/2009 | CN101374834A Compounds and methods for modulating FXR |
| 02/25/2009 | CN101374830A Alpha2C adrenoreceptor agonists |
| 02/25/2009 | CN101374828A Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 02/25/2009 | CN101374823A Organic compounds |